Jubilant Cadista Pharmaceuticals recalls

Jubilant Cadista Pharmaceuticals has 31 recalls on record with the FDA and USDA, the earliest in 2013 and the latest reported on 11 Jan 2023. The most frequent reason is potency & assay.

Total recalls31since 2013
Last 12 months0reported
Class I26% of total
Ongoing0latest 11 Jan 2023

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 2 6%Class II 11 35%Class III 18 58%

By year

All jubilant cadista pharmaceuticals recalls, newest first

31 total
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIIProchlorperazine Maleate Tablets, USP 5mg recalled by Jubilant CadistaProchlorperazine MaleateJubilant Cadista PharmaceuticalsPotency & AssayNationwide
DrugCLASS IIIrbesartan Tablets, USP, 150mg recalled by Jubilant CadistaIrbesartanJubilant Cadista PharmaceuticalsPotency & AssayNationwide
DrugCLASS IIIrbesartan Tablets, USP, 75 mg recalled by Jubilant CadistaIrbesartanJubilant Cadista PharmaceuticalsPotency & AssayNationwide
DrugCLASS IIIMethylprednisolone Tablets, USP 4mg recalled by Jubilant CadistaJubilant Cadista PharmaceuticalsPotency & AssayNationwide
DrugCLASS IMeclizine Hydrochloride Tablets USP, 5 mg recalled by Jubilant CadistaMeclizine HydrochlorideJubilant Cadista PharmaceuticalsLabeling Errors5 states
DrugCLASS IIIDonepezil HCL Tablets, USP, 5 mg recalled by Jubilant CadistaJubilant Cadista PharmaceuticalsPotency & AssayNationwide
DrugCLASS IIItraconazole Capsules, 100 mg recalled by Jubilant CadistaJubilant Cadista PharmaceuticalsPotency & AssayNationwide
DrugCLASS IIIMethylprednisolone Tablets USP, 4 MG recalled by Jubilant CadistaJubilant Cadista PharmaceuticalsPackaging DefectsNationwide
DrugCLASS IIclomiPRAMINE Hydrochloride Capsules USP, 50 mg recalledJubilant Cadista PharmaceuticalsOtherNationwide
DrugCLASS IIIOlanzapine Orally Disintegrating Tablets, 5 mg ( unit dose) recalledJubilant Cadista PharmaceuticalsPotency & AssayNationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.